| RS2132804872 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132804878 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2132805056 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132805287 |
CDH23
|
Health Risk |
Likely pathogenic |
Ear malformation, Ear malformation |
| RS2132807272 |
CDHR1
|
Health Risk |
Likely pathogenic |
— |
| RS2132809028 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS2132809199 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2132811750 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2132813703 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS2132817885 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
RET-related disorder, Hereditary cancer-predisposing syndrome |
| RS2132820119 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2132820242 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132820264 |
CDH23
|
Health Risk |
Pathogenic |
Pituitary adenoma 5, multiple types |
| RS2132820475 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132820703 |
CHAT
|
Health Risk |
Pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2132820982 |
CDHR1
|
Health Risk |
Likely pathogenic |
— |
| RS2132822152 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132825843 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS2132826154 |
WAC
|
Health Risk |
Likely pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS2132826354 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132828209 |
ELN
|
Health Risk |
Likely pathogenic |
Cutis laxa, autosomal dominant 1 |
| RS2132830435 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2132830490 |
COL5A1
|
Health Risk |
Pathogenic |
— |
| RS2132831777 |
BICC1
|
Health Risk |
Likely pathogenic |
Renal dysplasia, cystic |
| RS2132833489 |
CDHR1
|
Health Risk |
Likely pathogenic |
— |
| RS2132833694 |
WAC
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2132833820 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS2132834429 |
WAC
|
Health Risk |
Likely pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS2132836781 |
CDHR1
|
Health Risk |
Pathogenic |
— |
| RS2132838808 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132841152 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132841425 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132841517 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132844990 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132845192 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132846050 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132846322 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132847951 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS2132848217 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2132848313 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132852540 |
CHAT
|
Health Risk |
Pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2132852801 |
WAC
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2132853185 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS2132853537 |
IL2RA
|
Health Risk |
Likely pathogenic |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS2132853580 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS2132854041 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2132855762 |
PLCE1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2132856009 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS2132856138 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132858731 |
FREM1
|
Health Risk |
Pathogenic |
— |
| RS2132862248 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS2132862551 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome, DeSanto-Shinawi syndrome |
| RS2132863198 |
WAC
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2132864123 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132864295 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132864714 |
FREM1
|
Health Risk |
Pathogenic |
— |
| RS2132864817 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132864836 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132864849 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132865321 |
COL5A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2132871580 |
HK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental delay, Retinitis pigmentosa 79 |
| RS2132872003 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS2132874649 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132879262 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2132880685 |
NTRK2
|
Health Risk |
Likely pathogenic |
— |
| RS2132883536 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132884146 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132884703 |
HK1
|
Health Risk |
Likely pathogenic |
Hemolytic anemia due to hexokinase deficiency, Hemolytic anemia due to hexokinase deficiency |
| RS2132887747 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2132887783 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132897818 |
WT1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 4 |
| RS2132898640 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS2132898667 |
WT1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 4 |
| RS2132898935 |
WT1
|
Health Risk |
Likely pathogenic |
WT1-related disorder, 6 conditions |
| RS2132900093 |
WT1
|
Health Risk |
Likely pathogenic |
— |
| RS2132901145 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2132902301 |
RET
|
Health Risk |
Pathogenic |
— |
| RS2132913527 |
WT1
|
Health Risk |
Pathogenic |
Frasier syndrome, Frasier syndrome |
| RS2132913596 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, WT1-related disorder |
| RS2132914663 |
WT1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 4 |
| RS2132914929 |
WT1
|
Health Risk |
Likely pathogenic |
Frasier syndrome, Nephrotic syndrome |
| RS2132915129 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2132915155 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2132915429 |
WT1
|
Health Risk |
Likely pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2132919246 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2132919280 |
WT1
|
Health Risk |
Pathogenic/Likely pathogenic |
WT1-related disorder, 6 conditions |
| RS2132920130 |
WT1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 4 |
| RS2132920206 |
WT1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 4 |
| RS2132920775 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2132921573 |
WT1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 4 |
| RS2132925550 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132925640 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132925663 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132925682 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132925769 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132926166 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2132927249 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2132927381 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132929231 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2132929303 |
CDH23
|
Health Risk |
Pathogenic |
— |